Nifty Pharma Index Underperforms in 2025: A Stock-Picker’s Market
The Nifty Pharma index slipped nearly 3% in 2025 due to US pricing pressure, regulatory worries, and trade jitters. However, some pharma stocks delivered double-digit gains, rewarding investors who looked beyond the index.